Polarity defects are frequently involved in liver diseases, such as chronic hepatitis and hepatocellular carcinoma (HCC). It was reported that vacuolar protein sorting 33B (Vps33b) plays critical roles in the maintenance of hepatocyte polarity; however, the functional roles and mechanisms of Vps33b in HCC occurrence and progression remain unknown. First of all, we showed that Vps33b is down-regulated in human and mouse liver cancer samples, and the low expression levels of Vps33b correlate with the poor prognosis of many HCC patients. Liver-specific Vps33b deficiency induces liver damage, progressive hepatitis, fibrosis, and HCC in male mice, indicating that Vps33b is a crucial contributory factor to hepatocarcinogenesis. Vps33b deficiency-caused liver damage was primarily due to the disorders of structural and functional hepatocyte polarity, which were reflected by the decreased protein levels of E-cadherin because of inaccurate location to lysosomes and polarity defects at both apical and lateral plasma membrane proteins. The results of a mechanism study revealed that Vps33b interacts with VPS33B-interacting protein, which is involved in polarity and apical protein restriction; vesicle-trafficking protein Sec22b; and Flotillin-1 in hepatocytes and is in charge of the normal distribution of polarity-determined proteins. Expression levels of Vps33b negatively correlated with the degree of inflammatory cell infiltration in livers from diethylnitrosamineinduced or transgenic HCC mouse models, and the inflammatory stimuli suppressed the expression of Vps33b in vitro.
H epatocytes are highly polarized polygonal cells. The hepatic multipolar membrane system is a unique structure, with basal membrane contacting liver sinusoidal endothelial cells and multiple apical poles forming bile canaliculi.
(1) Establishment and maintenance of hepatocyte polarity require cell adhesion molecules, cell junctions, cytoskeleton, extracellular matrix, and intracellular trafficking proteins. (2) Hepatic polarity is critical for supporting liver lobule structure and normal physiological functions such as directional secretion of bile acid into the bile canaliculi and lipid transfer from sinusoidal blood. (3) Defects in hepatocyte polarization result in chronic hepatitis, cirrhosis, and even hepatocellular carcinoma (HCC). (4, 5) HCC is a common cause of cancer-related deaths worldwide. HCC mostly develops from chronic hepatitis virus infection (hepatitis B virus [HBV] or hepatitis C virus [HCV] ) or exposure to toxins (alcohol or aflatoxin). HCC lesions always emerge with abnormal tissue architecture, featuring polar modality with deficiency or abnormal location of surface molecules. Hepatocyte polarization and canalicular network formation require coordinated expression of several key evolutionarily conserved elements. E-cadherin is an intercellular adhesion molecule that plays a pivotal role in apical junctional complex formation and the maintenance of hepatocyte polarity. (6) Many studies have shown that HBV and HCV infections affect hepatic polarity by suppression of E-cadherin expression through multiple mechanisms including epigenetic modifications, down-regulation of microRNA-373, and up-regulation of SNAIL expression. (7, 8) The down-regulation of E-cadherin and subsequent perturbation of polarity have a direct effect on promoting epithelial-mesenchymal transition (EMT) and invasion in HCC. Moreover, HCV productive infection and HCV virion release occur mainly from the basolateral domain of hepatocytes, and tight junction proteins claudin 1 and occludin were found to be important for HCV entry. (9) Therefore, the polarity of hepatocytes is a key regulation factor for HCC malignant progression.
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Recently, the intracellular trafficking protein vacuolar protein sorting 33 homologue B (Vps33b) was shown to play roles in the maintenance of hepatic polarity. (10) Vps33b is a member of the Sec1/Munc18 family of class C vacuolar protein sorting proteins. Mutations of Vps33b cause arthrogryposis renal dysfunction cholestasis (ARC) syndrome, a severe autosomal recessive multisystem disorder including neonatal cholestatic jaundice, renal tubular acidosis, arthrogryposis, and failure to thrive. (11, 12) Hepatocyte pigment accumulation, giant-cell transformation, hepatitis, and significantly increased alkaline phosphatase (ALP) activity always present in ARC patient liver biopsies. Liver-specific Vps33b deficiency in mice caused abnormal location of apical membrane proteins and loss of functional tight junction integrity, confirming that Vps33b is a crucial regulator of hepatocyte polarity. (10) Previously, Vps33b and its partner VPS33B-interacting protein involved in polarity and apical protein restriction (VIPAR) were proposed to comprise class C core vacuole/endosome tethering (CORVET) and homotypic fusion and vacuole protein sorting (HOPS) multiprotein complexes and to participate in vesicle-mediated protein trafficking to the late endosomes/multivesicular bodies and lysosomal compartments. (13, 14) Recently, the Vps33b/VIPAR complex was proposed as the class C homologs in endosome-vesicle interaction (CHEVI) complex, which acts as a tethering complex in endosomal trafficking in mammalian cells. A recent study suggests that the Vps33b/VIPAR complex interacts with RAB11A to regulate membrane trafficking of recycling endosomes, thereby maintaining hepatocyte polarity. (10) aRtICle INFoRMatIoN:
The Vps33b/VIPAR/RAB11A complex plays a key role in sustaining liver physiological structure and function. (15) Our previous studies showed that Vps33b could also associate with VIPAR, Sec22b, GDI2, Flotillin-1 (Flot1), and RAB11A to regulate hematopoietically derived exosome maturation and secretion and megakaryocytic α-granule formation. (16) These results suggested a distinct mechanism of Vps33b-mediated CHEVI function in diverse cell types and organelles under different physiological and pathological conditions.
Although the functions of Vps33b in maintaining hepatocyte polarity have been studied, the potential roles and mechanisms of Vps33b in HCC progression are not yet clear. In this study, using HCC tissue samples as well as a liver-specific, Vps33b-deficient mouse model and biochemical technology, we elucidate the roles of Vps33b in HCC progression and underlying potential mechanisms.
Patients and Methods

patIeNtS aND DeSIgN
A total of 171 HCC patients who underwent partial hepatectomy in Eastern Hepatobiliary Surgery Hospital (Shanghai, China) were included from June 2009 to December 2010 according to the guidelines. (17) Each patient was diagnosed for the first time and had received no antitumor treatment before surgery. All of them were followed until September 2012, with the longest observation time being 39 months. Overall survival (OS) and disease-free survival (DFS) were defined as the interval between the dates of surgery and death or recurrence, respectively; if recurrence was not diagnosed, patients were censored on the date of death or the last follow-up. (18) For immunohistochemical (IHC) analysis, matched pairs of peritumor tissues and tumor tissues of HCC were used in the construction of a tissue microarray. The IHC staining of Vps33b was assessed as described. (19) Then, the median of the ratio of the IHC score between peritumor tissues and tumor tissues was used as a cutoff point to divide patient into two groups: lower group and normal group (ratio is equal to or greater or lower than median, respectively 
HIStologICal aND IHC aNalySeS
Liver tissues from anti-cluster of differentiation 137 (CD137) monoclonal antibody-treated HBVtransgenic mice (20) and diethylnitrosamine (DEN)-treated C57BL/6 wild-type mice (21) were kindly provided by S.W. and X.T., respectively.
Mouse liver tissues were fixed in 4% paraformaldehyde for 48 hours, embedded in paraffin wax, and sectioned by a semiautomated rotary microtome (Leica; RM2235). Hematoxylin and eosin (H&E) staining was used to detect the morphologic changes of livers in Vps33b knockout mice. Distributions of Vps33b, low-density lipoprotein (LDL) receptor (LDLR), scavenger receptor class B member 1 (SRB1), E-cadherin, adenosine triphosphate-binding cassette subfamily G member 5 (ABCG5) and ABCG8 in livers were detected by IHC following standard procedures. Sections were stained with ImmPACT DAB Peroxidase Substrate (Vector Labs, Burlingame, CA), counterstained with hematoxylin, and mounted.
HepatoCyte ISolatIoN aND CUltURe
Primary mouse hepatocytes were isolated using the collagenase IV perfusion method, based on the modified two-step collagenase perfusion for isolation of intact hepatocytes. (22) Briefly, mice were anesthetized, spiled through the portal vein, and irrigated with Ca 2+ -free D-hanks (GIBCO), followed by 20 mL 0.5 g/L collagenase IV (GIBCO) digestion for 8 minutes. Then, the cell suspension was mixed with precooled 1 × phosphate-buffered saline (PBS) for termination of digestion. After filtering through a 100-μm pore size mesh nylon filter, the suspension was centrifuged at 500 rpm at 4°C for 5 minutes and washed with 1×PBS 3 times. Finally, the pellet was resuspended and cultured in Hepatocyte Medium (Sciencell). After 24 hours, hepatocytes were washed with prewarmed PBS and replaced with Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 4.5 g/L glucose, 4 mM L-glutamine, and 100 μg/mL penicillin/streptomycin (Hyclone), for additional time to culture.
StatIStICal aNalySIS
Data are shown as the mean ± standard deviation (SD). Statistical differences between control groups and knockout groups were analyzed by two-tailed Student t tests. Statistical analyses were performed using GraphPad Prism (San Diego, CA).
Results
DoWN-RegUlatIoN oF VpS33B eXpReSSIoN CoRRelateS WItH tHe pRogNoSIS oF HCC
To investigate Vps33b expression in HCC tissues, tissue microarray analysis from 171 patients who underwent hepatectomy was performed. The results showed that the average expression level of Vps33b was significantly lower in tumor tissues than that in peritumoral tissues (Fig. 1A,B) . According to the IHC results, all 171 HCC patients were divided into two groups: normal Vps33b expression (n = 85) and low Vps33b expression (n = 86). Clinical characteristics of the patients are shown in Supporting Table S1 . We found that patients with lower Vps33b had significantly poor pathologic differentiation (P = 0.011), more satellite node (P = 0.004), portal vein tumor thrombus (P = 0.039), and higher alpha-fetoprotein (AFP) levels (P = 0.006) than those in the normal group.
In view of the above-mentioned Vps33b involvement in the occurrence and development of liver cancer, we further examined whether Vps33b expression levels correlated with the outcome of HCC patients after hepatectomy. Kaplan-Meier survival analysis showed the differences in OS and DFS between the two groups. Patients in the lower Vps33b expression group revealed shorter DFS (median DFS time, 14.3 and 18.4 months, respectively; difference, 4.1 months; P = 0.031) and OS (median OS time, 23.9 and 29.4 months, respectively; difference, 5.5 months; P = 0.008) than those in the normal expression group (Fig.  1C,D) . Then, we examined the prognostic value of Vps33b expression by multivariate analysis using the Cox proportional hazards model. The results revealed that Vps33b expression was an independent risk factor of poor outcome of HCC patients (Supporting Table S2 ).
Moreover, the data in Supporting Table S1 showed the percentage of cases with low Vps33b expression to be 25% (4/16) and 53% (82/155) in female and male HCC groups, respectively (P = 0.034). In the lowVps33b expression group, 95.3% (82/86) were male but only 4.7% (4/86) were female. This indicated that Vps33b is more correlated with hepatocarcinogenesis in male patients.
lIVeR-SpeCIFIC Vps33b DeFICIeNCy CaUSeS HCC
Patients with ARC syndrome died in infancy, mostly in the first 6 months of life due to failure of thrive (23, 24) ; therefore, it is impractical to observe the function of Vps33b in chronic hepatic pathology. Then, liver-specific, Vps33b-defient mice were generated by crossing mice carrying Vps33b exons 2-3 flanked by loxP sites with albumin promoter Cre recombinase transgenic mice. Vps33b
Alb-Cre + (Vps33b -/-) mice were genotyped by PCR. Primary hepatocytes were separated from 4-month-old Vps33b -/-and Vps33b f/f livers, and western blotting results showed that Vps33b was fully deleted in Vps33b -/-mouse hepatocytes ( Fig. 2A) . No significant differences were found between Vps33b -/-and Vps33b f/f mice born at our animal facility. To study the spontaneous development of potential liver pathologies, Vps33b
-/-and Vps33b f/f mice were monitored for up to 18 months under conventional housing conditions. Vps33b -/-and Vps33b f/f mice were matched for age and gender. At the age of 1 month, the weight, liver morphology, and relative liver weight of Vps33b -/-mice showed no difference from those of Vps33b f/f littermate control mice (Fig. 2B-D) .
However, the weight of Vps33b -/-mice became slightly heavier than their Vps33b f/f counterparts as they aged (Fig. 2B ). Vps33b-deficient mice had a significant hepatauxe appearance, and some Vps33b -/-mouse livers presented a rough surface and massive large nodules (Fig. 2C) . The incidence of male mice harboring liver nodules was approximately 32% at the age of 12 months, and over the age of 18 months the incidence reached 69% ( Fig. 2E ; Supporting Table S3 ).
Histopathologic examination of Vps33b -/-mouse liver nodules revealed many characteristics of HCC. Cytologically, Vps33b -/-nodules showed an increase in cell size and nuclear to cytoplasmic ratio, hyperchromasia, loss of cytoplasmic staining (Fig. 2F) , and necrosis (data not shown). And most of the nodules were AFP-positive, which confirmed HCC formation in Vps33b -/-mice (Supporting Fig. S1A ). To further examine the tumor-suppressive role of Vps33b, Vps33b f/f and Vps33b -/-mice were injected with DEN. At the age of 5 months, AFP staining was already positive in Vps33b -/-livers, while AFP staining was negative in Vps33b f/f mice (Supporting Fig.  S4C ), indicating that Vps33b -/-mice were also more susceptible to a chemically induced HCC development. Taken together, these results reveal a direct link between Vps33b and hepatic carcinogenesis. All data represent means ± SD (n = 171). *P < 0.05, **P < 0.01, and ***P < 0.001. (C,D) Kaplan-Meier analysis of correlations between DFS (C) or overall survival (D) of 171 HCC patients and Vps33b expression level. Based on Vps33b staining analysis of the liver samples, HCC patients were divided into normal-Vps33b expression (n = 85) and low-Vps33b expression (n = 86) groups. Survival of patients in the normal-Vps33b group was significantly higher than that of patients in the low-Vps33b group (P < 0.001, log-rank test).
To evaluate the roles of Vps33b in tumor cell proliferation and tumor growth, Vps33b was overexpressed in the SMMC-7721 hepatocarcinoma cell line. Cell proliferation in vitro was measured by the Cell Counting Kit-8 assay, and tumor growth was observed by subcutaneously injecting the cells into nude mice. Interestingly, no significant differences were found between Vps33b overexpression and control cells (Supporting Fig. S3C ), suggesting that Vps33b may serve as an important tumor suppressor in carcinogenesis of HCC instead of tumor growth.
Vps33b DeFICIeNCy CaUSeS lIVeR DaMage aND pRogReSSIVe HepatItIS aND FIBRoSIS
Hanley et al. recently reported that AlfpCre-driven, hepatocyte-specific Vps33b deficiency caused slight enhancement of alanine aminotransferase (ALT) activity and significant increases of the levels of ALP activity, total bile acid (TBA), and total cholesterol (TC) in plasma from 14-week-old deficient mice due to the hepatobiliary injury. Alfp-Cre mice delete gene expression under Crerecombinase completely in the fetal liver, while AlbCre mice completely delete gene expression at 2 weeks after birth. To observe the effects of Alb-Cre-driven Vps33b deficiency on postembryonic hepatocyte injury, the plasma levels of ALT, ALP, TBA, and TC at the ages of 1 month, 4 months, 8 months, and 12 months were measured in Vps33b -/-mice. Serum level of ALT is the most sensitive index of liver injury. (25) Though the levels of ALT showed no difference between Vps33b-deficient and littermate control mice at a young age (1 month), ALT levels in Vps33b -/-mice plasma progressively increased from the age of 4 months, and an approximate 10-fold increase was observed at the age of 12 months (Fig. 3A) . ALP, a test index indicating possible problems in the liver, (26) was also significantly elevated in Vps33b -/-mice compared with the littermate control group at the indicated times over 1 year (Fig. 3A) . Cholestasis is one of the main features of Vps33b mutation, (27) so plasma TBA levels were also measured. The data presented in Fig. 3A demonstrate that TBA increased in the Vps33b -/-mice in an age-dependent manner. These results confirmed that Vps33b deficiency causes liver injury. Pathological changes were observed by H&E staining of Vps33b -/-and Vps33b f/f mouse liver sections. The H&E staining results in Fig. 3B demonstrate that there were no significant differences in the tissue structure and inflammatory cell infiltration in livers between Vps33b -/-and Vps33b f/f mice at the age of 1 month. However, Vps33b -/-mice showed significant changes of liver structure and inflammatory cell infiltration starting from 4 months of age (Fig.  3B,C) . And livers from 12-month-old Vps33b -/-mice showed severe inflammatory cell infiltration and distinct necrotic areas (Fig. 3B) . The inflammatory cells consisted of macrophages and neutrophils, as indicated by IHC staining of CD68 and Gr1, respectively (Supporting Fig. S1B,C) . The positive trichrome staining of liver sections from Vps33b -/-and Vps33b f/f mice revealed remarkable fibrosis in Vps33b-deficient livers at age >4 months (Fig. 3D,E ). This fibrotic change may indicate a response to inflammation caused by Vps33b defects. Hepatitis and fibrosis were found in all of the 12-month-old Vps33b -/-mice, while only 32% of mice developed HCC at this age, and the incidence increased as aging (Supporting Table S3 ). These results suggest that Vps33b deficiency in hepatocytes sequentially leads to liver injury, inflammation, fibrosis, and eventual HCC.
Vps33b DeFICIeNCy CaUSeS polaRIty DeFeCtS at BotH apICal aND lateRal plaSMa MeMBRaNe pRoteINS
Vps33b has been shown to regulate the trafficking of apical (canalicular) membrane proteins and, therefore, bile canaliculi structure and function. (28) To confirm the role of Vps33b in bile canaliculi structure and function, transmission electron micrographs of bile canaliculi in Vps33b f/f and Vps33b -/-mouse livers were captured. The images in Fig. 4A show that AlbCre-driven Vps33b deficiency causes an apparent lack of canalicular microvilli, and surprisingly there is a significant increase of lysosomes in Vps33b-deficient hepatocytes. Double-immunofluorescence staining was further performed to characterize the fault location of specific apical and lateral membrane proteins; the results in Fig. 4B demonstrate the disorganized localization of both canalicula-specific protein CD26 and lateral membrane protein transferring receptor (TFR) in the Vps33b -/-liver. Therefore, Vps33b deficiency caused polarity defects at both apical and lateral plasma membrane.
We postulated that abnormal serum cholesterol might be caused by disruption of apical and lateral plasma membrane transporters. LDLR and SRB1 are the hepatocyte sinusoid side membrane proteins. LDLR is responsible for the endocytosis of cholesterol-rich LDL and regulation of cholesterol metabolism. SRB1 can facilitate the uptake of cholesteryl esters from high-density lipoproteins in the liver and the movement of cholesterol from peripheral tissues toward the liver. ABCG8 and ABCG5 are members of the superfamily of adenosine triphosphate-binding cassette (ABC) transporters. ABCG8 and ABCG5 are strongly expressed in the canalicular hepatocyte membrane and play an important role in hepatobiliary cholesterol transport and sterol efflux into the bile. First of all, the expression levels of LDLR, SRB1, ABCG8, and ABCG5 were tested in 4-month-old Vps33b f/f and Vps33b -/-mouse hepatocytes; the results in Fig. 4C and Supporting Fig. S2A ,B demonstrate that Vps33b deficiency has no effects on the expression levels of LDLR, SRB1, ABCG8, and ABCG5.
Then, the expression profiles of these membrane proteins in liver biopsy specimens were measured. IHC results revealed that ABCG8, normally localized in the apical domain of hepatocytes in Vps33b f/f mice, was abnormally localized in the hepatocyte cytoplasm of 12-month-old Vps33b -/-mice, while no obvious IHC abnormalities of ABCG5 in Vps33b -/-mice were found (Fig. 4D) . Interestingly, the immunostaining results showed that the distribution pattern of LDLR and SRB1 was significantly altered in Vps33b -/-mice compared with Vps33b f/f mice (Fig. 4E) . These results suggested that abnormal polarity distribution of ABCG8, LDLR, and SRB1 might contribute to the hypercholesterolemia in Vps33b -/-mice.
Vps33b DeFICIeNCy CaUSeS INaCCURate loCatIoN oF e-CaDHeRIN to lySoSoMeS
Adherens junction protein E-cadherin is important for polarization formation of hepatocytes, and inactivation of human E-cadherin is strongly associated with tumorigenesis and increased cancer invasiveness. (29, 30) It was reported that E-cadherin decreased immunohistochemically in patients with ARC syndrome. (15) Abnormal expression of E-cadherin and defective epithelial polarization in ARC syndromes with Vps33b defects may link the human Vps33b complex to common diseases such as inflammation and cancer. (15) Therefore, the expression and cellular distribution of E-cadherin in Vps33b f/f and Vps33b -/-mice liver were studied. The results presented in Fig. 5A showed that expression of E-cadherin dramatically decreased in
4-month-old Vps33b
-/-mouse liver. And the mRNA levels of E-cadherin were not affected in Vps33b -/-mouse liver (Fig. 5B) , suggesting that Vps33b deficiency-driven low expression of E-cadherin was not through a transcription-dependent pathway.
To further study the cause of decreased expression of E-cadherin in Vps33b -/-mouse liver, the cellular location of E-cadherin was analyzed by immunofluorescence. The results in Fig. 5C show that E-cadherin mostly located on the lateral plasma membrane in Vps33b f/f mouse liver; however, most of the E-cadherin loss was at the lateral location, with detectable E-cadherin located in the cytoplasm in Vps33b -/-mouse liver. Further costaining of E-cadherin and lysosome-associated membrane protein 1 (Lamp1), a marker of late endosome or lysosome, showed that most of the detectable E-cadherin colocalized with augmented lysosome in the cytoplasm in Vps33b -/-mouse liver ( Fig. 5D ; Supporting  Fig. S2C ). Therefore, Vps33b is a critical regulator of the posttranslational location of E-cadherin.
Loss of E-cadherin leads to EMT induction and up-regulation of stem cell markers. (30) IHC with the mesenchymal marker vimentin and the stem cell marker CD44 was performed in Vps33b f/f and Vps33b -/-livers. The results in Supporting Fig. S3A ,B show that vimentin and CD44-positive cells appeared in 8-month-old Vps33b -/-livers, indicating that EMT-like transformation occurred and hepatocytes regained stem cell features.
Vps33b INteRaCtS WItH Vps16b, Sec22b, aND Flot1 IN HepatoCyteS
Our previous studies showed that Vps33b can associate with Vps16b, Flot1, Sec22b, GDI2, RAB11a, and RAB27a in human embryonic kidney 293T (HEK293T) cells. Vps33b complex can regulate megakaryocyte α-granule formation and exosomal autocrine signaling for hematopoiesis and leukemogenesis. (31) Here, the association of Vps33b with Vps16b, Flot1, and Sec22b in hemagglutinin-Vps33b-transfected HepG2 or primary mouse hepatocytes was confirmed using coimmunoprecipitation experiments (Fig. 6A-C) . Western blotting after pull-down confirmed interactions of exogenous Vps33b with Vps16b, Sec22b, and Flot1; and mouse immunoglobulin G was used as a negative control (Fig. 6B) . To confirm the endogenous binding of Vps33b with Vps16b, Sec22b, and Flot1, coimmunoprecipitation of the Vps33b complexes was carried out; and the results showed that Vps33b could associate endogenously with Vps16b, Sec22b, and Flot1 in primary mouse hepatocytes (Fig. 6C) . Our previous study already showed that Sec22b bound to full-length Vps33b and Vps33b1 (L146-A617) but not to the other truncated forms of Vps33b. Vps16b bound firmly to full-length Vps33b and slightly to Vps33b1 and Vps33b4. Here, we further tested the binding ability of Flot1 to bind to fulllength and various truncated forms of Vps33b. We found that Flot1 only binds to full-length Vps33b but not to the truncated forms of Vps33b (Fig. 6D) . These results suggested that the binding domains of Vps33b for Vps16b, Sec22b, and Flot1 involve more than the SEC1-like domain, which was reported to be important in the regulation of soluble N-ethylmaleimidesensitive factor attachment protein receptor (SNARE) complex formation. (32, 33) 
eXpReSSIoN oF Vps33b IS DoWN-RegUlateD IN HCC MoUSe MoDelS pRoBaBly By INFlaMMatoRy FaCtoR INteRleUKIN-6 aND tUMoR NeCRoSIS FaCtoR alpHa
Although we have identified that down-regulation of Vps33b expression correlated with the prognosis of HCC patients and that Vps33b deficiency facilitated hepatocarcinogenesis, the mechanism underlying down-regulation of Vps33b expression in HCC remains unclear. Persistent inflammation is known to promote and exacerbate malignancy. HCC is a clear example of inflammation-related cancer as >90% of HCCs arise in the context of hepatic injury and inflammation. First of all, the expression levels of Vps33b and the leukocyte counts were measured by IHC. The results presented in Fig. 7A-D and Supporting Fig. S4A ,B show that expression of Vps33b was significantly suppressed in CD137 antibody-treated HBV transgenic male mice or DEN/ high fat-treated wild-type male mice. The expression level of Vps33b showed a negative correlation with leukocyte infiltration, indicating that liver inflammation probably suppresses the expression of Vps33b in hepatocytes.
The inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα) have been shown to be important for HCC development. (34) IL-6 and TNFαlevels were much higher in tumor than peritumoral tissues in HCC patients (Supporting Fig. S5A,B) . To examine the mechanism of Vps33b down-regulation, primary hepatocytes were purified and treated with IL-6 and TNFα, respectively, or in combination. The results in Fig. 7E and Supporting Fig. S5C demonstrate that IL-6 and TNFα can significantly suppress the expression of Vps33b in mouse hepatocytes and that the combination of IL-6 and TNFαhas synergistic inhibitory effects on Vps33b expression. The phosphorylation of signal transducer and activator of transcription 3 (Stat3) and p65 were significantly enhanced in primary hepatocytes treated with IL-6 and TNFα, respectivelyS31-21 can block the DNA binding activity of Stat3. JSH-23 is a specific inhibitor of nuclear factor kappa B's (NFκB's) transcription activity. The data in Supporting Fig. S5D show that S31-21 and JSH-23 blocked the inhibitory effect of IL-6 and TNFα on Vps33b mRNA expression, respectively. Thus, IL-6 and TNFα may suppress Vps33b expression through the transcription activity of Stat3 and NFκB.
Therefore, the down-regulation of Vps33b expression in HCC was probably due to the liver inflammation.
Discussion
HCC is one of the most deadly human malignancies diagnosed worldwide. Many risk factors, including hepatitis viral infection, aflatoxin B1, and alcohol consumption, have been identified as causes of HCC pathogenesis. Although an increasing number of therapeutic strategies for patients and molecules for predicting HCC prognosis have been developed, the 5-year postoperative survival rate remains poor. This is mainly due to the key genes and molecular mechanisms involved in HCC development and progression remaining unclear.
Vps33b is a member of the Sec-1 domain family. Our previous work showed that Vps33b regulates von Willebrand factor-positive vesicular trafficking in megakaryocytes and exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis. (31) In the current study, we found that the expression levels of Vps33b significantly decreased in tumor from liver cancer mouse models and HCC patients. And lower Vps33b expression was related to a poor prognosis and advanced stages of HCC, which suggests that abnormality of Vps33b expression is associated with a poor prognosis of hepatocellular carcinogenesis. In our study, Alb-Cre-driven, Vps33b-deficient mice developed hepatitis, which progressed into hepatic fibrosis and finally HCC, further indicating that Vps33b plays critical roles in the entire process of hepatocarcinogenesis. The much higher incidence of liver cancer in male subjects is well known. Male mice produce far more IL-6 in response to liver injury than female mice, which has been proposed as the cause of their high incidence of liver cancer. In our study, the proinflammatory factor IL-6 and TNFα significantly suppressed Vps33b expression, and HCC occurred only in male Vps33b-deficient mice, which reflects not only an insight into Vps33b's involvement in inflammation-associated HCC but also that Vps33b is another factor in the gender bias of HCC. Further investigation of the mechanism of the gender bias of Vps33b in HCC incidence is required.
Apical plasma membranes with their microvilli and bile canaliculi network formation play important roles in hepatocyte structural polarity. (2) A recent study showed that Vps33b plays a role in the maintenance of the apical-basolateral polarity of hepatocytes.
(10) Consistently, we showed mislocalization of ABCG8 in hepatocyte cytoplasm instead of canaliculi membrane in livers of Vps33b -/-mice, confirming that Vps33b plays critical roles in maintaining the normal location of apical membrane proteins and bile canaliculi structure of hepatocytes. ABCG8 is a member of the ABC transporters and forms a heterodimer with ABCG5 to excrete cholesterol and plant sterols into bile. (35, 36) Mislocalization of ABCG8 may be partially responsible for abnormal serum cholesterol levels. (37) Although it has not been reported that there are polarity defects at the basal membrane domains in ARC patients' liver samples, interestingly we found that the location of hepatic lateral proteins LDLR and SRB1 is also abnormal in Vps33b-deficient mouse liver. LDLR mediates the endocytosis of cholesterol-rich LDL by recognizing the apoprotein B100. SRB1 is an integral membrane protein, facilitating the uptake of cholesteryl esters from high-density lipoproteins in the liver. Abnormal distribution of LDLR and SRB1 may disturb the absorption of cholesterol from plasma to liver, which may also be partially responsible for abnormal serum cholesterol levels. (37) Therefore, Vps33b plays very important roles in the maintenance of hepatic polarity and cholesterol homeostasis.
Among hepatocellular carcinogenesis mechanisms, alterations of cell adhesion junctions are important events. (38) Transmembrane protein E-cadherin, the major constituent of adherens junctions, is essential for the generation and maintenance of hepatocyte polarity. Recent studies have established links between abnormal expression of E-cadherin and hepatocellular carcinogenesis and invasiveness. In our study, we showed decreased expression of E-cadherin in livers of Vps33b
-/-mice due to mis-sorting toward lysosomes. This improper translocation of E-cadherin to lysosomes is a probable partial casualty of abnormal distribution of canalicula-specific protein CD26, ABCG8, and lateral membrane protein TFR, LDLR, and SRB1 and, therefore, abnormal hepatocyte polarity and hepatocarcinogenesis.
Vesicle-mediated protein sorting plays an important role in the segregation of intracellular molecules to distinct organelles. Vps33b, sharing high homology with yeast class C vacuolar protein sorting (vps) protein, belongs to the Sec1-Munc18 family. Class C vps protein usually interacts with multiple proteins to form two complexes, CORVET and HOPS. Recently, it was reported that the Vps33b/Vps16b complex was proposed as the CHEVI complex. (39) In our previous study, we identified that Vps33b associates with Vps16b, Flot1, Sec22b, GDI2, RAB11a, and RAB27a in HEK293T cells. (16) Here, we found that Vps33b, Vps16b, Flot1, and Sec22b form a complex in HepG2 cells. Flot1 was previously reported as a caveolae-associated integral membrane protein essential for vesicular endocytosis and cellular cholesterol uptake. (40) So we speculate that the Vps33b complex interacts with Flot1 to regulate ABCG8, LDLR, and SRB1 trafficking and therefore cholesterol transport in hepatocytes. Sec22b is a vesicle trafficking protein thought to complex with SNARE and plays a role in the mutual targeting and fusion of Golgi and endoplasmic reticulum-derived transport vesicles as well as in phagosomal maturation and plasma membrane expansion. (41, 42) Association of Vps33b with Sec22b may play a critical role in E-cadherin trafficking in hepatocytes. These results reflect the complexity of Vps33b function in hepatocytes, and more transgenic mouse models are required to address the functions of Vps33b in hepatocarcinogenesis.
In conclusion, our study revealed the critical role of vesicular transport protein Vps33b in liver homeostasis and inflammation-associated hepatocarcinogenesis. The Vps33b complex serves as an important target for predicting the prognosis and impelling the therapeutics of liver cancer.
